Understanding and Applying the 2025 “ILAs” (Interstitial lung abnormalities) Guidelines in Clinical Practice
Learning objectives:
Describe the key updates in the 2025 ILA guidelines
Identify clinical scenarios where early recognition of ILA may impact patient outcomes and guide timely referral and investigation
Apply the 2025 ILA recommendations through case discussions to guide patient management
Program date: November 5, 2025
Speaker: Amanda Grant-Orser MBBCh FRCPC
Clinical Assistant Professor
Respiratory Medicine, Department of Medicine, University of Calgary
Director, Foothills Medical Centre Interstitial Lung Disease Clinic
FMC Health Sciences Centre
Moderator: Christopher Ryerson MD, FRCPC
Professor
Department of Medicine and Centre for Heart Lung Innovation
University of British Columbia
Questions?
The presenters are solely responsible for developing the content of this presentation and maintaining scientific accuracy, objectivity, and balance. Any discussions of clinical practice or treatment represent the opinions of the presenter alone. This video is made available for attendees, registrants, and individuals requesting further information on this learning program.